Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jun 28, 2026
ORASURE TECHNOLOGIES INC (OSUR)
A forensic read on ORASURE TECHNOLOGIES INC built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Safe
Financial health
6.8
Altman Z-score
Clean
Earnings quality
5
Forensic signals
-21.5%
ROE
$307M
Market cap
ORASURE TECHNOLOGIES INC earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is 6.8, placing it in the Safe zone. 5 forensic signals were flagged in its latest SEC filings, led by receivables vs revenue.
What the filings flag
70d DSOReceivables vs revenue.Days sales outstanding moved from 47 to 70 days FY2024→FY2025 (receivables -7% vs revenue -38%). Receivables are outrunning sales — a flag for aggressive revenue recognition or slipping collections.
170dInventory days.Days inventory outstanding moved from 117 to 170 FY2024→FY2025 (against cost of goods sold; inventory -9% vs -37% in cost of sales). Inventory is outrunning what's being sold — a flag for softening demand or obsolescence risk ahead.
-35%Return on invested capital.Return on invested capital is -35% and slipping from -6% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
+0.5%/yrShare-count dilution.Diluted share count changed +1% over the last 3 years to FY2025 (+0.5%/yr). Roughly flat — buybacks are about offsetting stock comp, not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.
$4MGoodwill impairments.Took $4M of goodwill writedowns across 1 year(s) (FY2022 ($4M)). Writedowns mean past acquisitions underperformed what was paid for them — worth weighing on capital-allocation skill.
Key fundamentals
Net Margin-59.8%
Debt / Equity0.02x
Free Cash Flow$-53.2M
Latest Revenue$115.0M
Return on Equity-20.2%
Revenue Growth YoY-38.1%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on ORASURE TECHNOLOGIES INC:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about OSUR's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown